Back to search

Article

Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myasthenia

2024-02-12

Abstract excerpt

Congenital myasthenic syndromes (CMS) are a group of inherited disorders characterised by defective neuromuscular transmission and fatigable muscle weakness. Mutations in DOK7 , a gene encoding a post-synaptic protein crucial in the formation and stabilisation of the neuromuscular junction (NMJ), rank among the leading three prevalent causes of CMS in diverse populations globally. The majority of DOK7 CMS patient...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9657b32f-245c-5f1e-8a92-cebf8348dc47
DOI
10.1101/2024.02.09.579626
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dose escalation pre-clinical trial of novel DOK7-AAV in mouse model of DOK7 congenital myastheniaDOI 10.1101/2024.02.09.579626
Select a neighboring publication to make it the new centre.